NorthCrest Asset Manangement’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
Other funds holding ZBH
DLA
WAM
DJSG
QAM
NCM
SFA
GHAM
CNB
NorthCrest Asset Manangement's ZBH Position: Q2 2026 in Review
NorthCrest Asset Manangement increased its Zimmer Biomet (ZBH) stake by 4.3% in Q2 2026, buying an estimated $147K and bringing the position to 40,697 shares worth $3.63M. The position accounts for 0.09% of the portfolio, ranked #170.
NorthCrest Asset Manangement first reported a position in ZBH in Q4 2021 and has held it in 19 quarters since. The position peaked at $8.45M in Q2 2023. 150 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- NorthCrest Asset Manangement held 40,697 shares of Zimmer Biomet worth $3.63M as of Q2 2026.
- NorthCrest Asset Manangement bought 1,671 Zimmer Biomet shares in Q2 2026, an estimated $147K.
- Zimmer Biomet made up 0.09% of NorthCrest Asset Manangement's portfolio in Q2 2026, its #170 holding.
- NorthCrest Asset Manangement first reported a position in Zimmer Biomet in Q4 2021 and has held it in 19 quarters since.
- NorthCrest Asset Manangement's Zimmer Biomet position peaked at $8.45M in Q2 2023.
- 150 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.